4.5 Article

Melatonin does not reduce mortality in adult hospitalized patients with COVID-19: a multicenter retrospective observational study

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study

Nicolas Hoertel et al.

Summary: This study suggests that the use of antidepressants in patients hospitalized for COVID-19 may be associated with a lower risk of death or intubation. Antidepressants such as fluoxetine, paroxetine, escitalopram, venlafaxine, and mirtazapine showed significant associations with reduced risk. Further research in the form of double-blind controlled randomized clinical trials is recommended.

MOLECULAR PSYCHIATRY (2021)

Article Pharmacology & Pharmacy

Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study

Nicolas Hoertel et al.

Summary: The use of FIASMA medication in COVID-19 patients may reduce the risk of intubation or death, with this association remaining significant in multiple sensitivity analyses and not specific to a particular FIASMA class or medication. Double-blind controlled randomized clinical trials are needed to further investigate the potential benefits of these medications for COVID-19.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Review Medicine, Research & Experimental

COVID-19: Melatonin as a potential adjuvant treatment

Rui Zhang et al.

LIFE SCIENCES (2020)

Article Biochemistry & Molecular Biology

A stochastic agent-based model of the SARS-CoV-2 epidemic in France

Nicolas Hoertel et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

COVID-19: Rational discovery of the therapeutic potential of Melatonin as a SARS-CoV-2 main Protease Inhibitor

Eduardo L. Feitosa et al.

INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)